Status:
RECRUITING
Stanford Pragmatic Effectiveness Comparison
Lead Sponsor:
Stanford University
Conditions:
Chronic Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Chronic pain is a major healthcare problem with an annual cost of above $600 billion. The quality of data available for treatments of chronic pain is not optimal. Generalizability of explanatory rando...
Detailed Description
This study aims to increase generalizability of clinical data for current treatments of chronic pain by integrating pragmatic comparative effectiveness research within patient care. Chronic pain is a...
Eligibility Criteria
Inclusion
- Age of 18 years old or above
- Persistent pain for more than 3 months
- Candidate for treatment by anti-convulsants or anti-depressants based on treating pain provider
- Equipoise between anti-convulsants and anti-depressants according to the treating pain provider
Exclusion
- Contraindication to taking anti-convulsants or anti-depressants: this exclusion is based on the judgement of the treating pain provider; e.g. if the patient is on a large dose of serotonin specific reuptake inhibitor (SSRI) anti-depressant, it will stop the physician from considering any other anti-depressants; thus, excluding the patient
- Patient refusal
Key Trial Info
Start Date :
April 12 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2026
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT04441034
Start Date
April 12 2022
End Date
April 30 2026
Last Update
March 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford Pain Management Center
Redwood City, California, United States, 94063